Pilot Study of Combination Chemotherapy Using Irinotecan plus S-1 for Metastatic Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|75|1-2|67-70

ISSN： 0030-2414

Source： Oncology, Vol.75, Iss.1-2, 2008-08, pp. : 67-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer

By  

Oncology, Vol. 77, Iss. 5, 2009-11 ,pp. : 300-303

Karger

Access to resources Recommend Favorite

A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study)

By  

Oncology, Vol. 91, Iss. 1, 2016-05 ,pp. : 24-30

Karger

Access to resources Recommend Favorite

A Phase II Trial of Combined Chemotherapy with Oral S-1 and 24-Hour Infusions of Irinotecan plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 353-359

Karger

Access to resources Recommend Favorite

Biweekly gemcitabine plus S‐1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 9, 2015-09 ,pp. : 692-698

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase I Study of Combination Chemotherapy with Gemcitabine and Oral S-1 for Advanced Pancreatic Cancer

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 421-427

Karger

Access to resources Recommend Favorite